XOMA Royalty completes acquisition of Mural Oncology for $2.035/share

XOMA Royalty Corp

Deal closed Dec 5, 2025; Mural shareholders received $2.035 cash per share.
Transaction approved by Mural shareholders on Oct 24, 2025; Irish High Court sanctioned Dec 3.
Mural shares ceased trading on Nasdaq effective Dec 5; will be delisted and deregistered.
XOMA Royalty acquired entire share capital of Mural via Irish scheme of arrangement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.